AG938
Synuclein, α, recombinant human
Sinônimo(s):
α-Synuclein protein, Alpha Synuclein
Faça loginpara ver os preços organizacionais e de contrato
About This Item
Produtos recomendados
fonte biológica
human
Nível de qualidade
Ensaio
>95% (gel scan and mass spectrometry)
forma
solid
prazo de validade
12 mo.
fabricante/nome comercial
Chemicon®
solubilidade
water: slightly soluble
adequação
suitable for molecular biology
nº de adesão NCBI
nº de adesão UniProt
Informações sobre genes
human ... SNCA(6622)
Descrição geral
Research area: Neuroscience
α-Synuclein, a member of the synuclein family of proteins that localize to presynaptic terminals under physiological conditions. It is comprised of three primary regions: an amino terminus containing apolipoprotein lipid-binding motifs, which are anticipated to form amphiphilic helices. The central region, known as non-Aβ component (NAC) containing a hydrophobic domain that gives β-sheet potential, and the carboxyl terminus, characterized by a high negative charge and remains unstructured. Under physiological conditions, members of the synuclein family, including α-synuclein, are predominantly neuronal proteins.
α-Synuclein, a member of the synuclein family of proteins that localize to presynaptic terminals under physiological conditions. It is comprised of three primary regions: an amino terminus containing apolipoprotein lipid-binding motifs, which are anticipated to form amphiphilic helices. The central region, known as non-Aβ component (NAC) containing a hydrophobic domain that gives β-sheet potential, and the carboxyl terminus, characterized by a high negative charge and remains unstructured. Under physiological conditions, members of the synuclein family, including α-synuclein, are predominantly neuronal proteins.
Aplicação
Synuclein, α, recombinant human has been used:
- for preparation of α-synuclein fibrils to access the SAR228810 antibody against the risk of amyloid-related imaging abnormalities (ARIA).
- to study the formation of isoasparate protein damage responsible to trigger familial Parkionsonian phenotypes.
- to study its interaction with iron and copper, in order to understand their role in proteinopathies.
Ações bioquímicas/fisiológicas
Synuclein, α is the principal component of Lewy bodies and a pathological hallmark of synucleinopathies, including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). The deposition of αS aggregates is a defining characteristic of all these diseases.
forma física
Lyophilized from TBS. Resuspend in water at a concentration of 1 mg/mL.
Armazenamento e estabilidade
Maintain lyophilized material at -20ºC for up to 12 months after date of receipt. After reconstitution maintain at -20ºC to -70ºC for up to 2 weeks in undiluted aliquots. Avoid freeze/thaw cycles to avoid aggregation.
Informações legais
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Exoneração de responsabilidade
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Código de classe de armazenamento
13 - Non Combustible Solids
Classe de risco de água (WGK)
WGK 1
Ponto de fulgor (°F)
Not applicable
Ponto de fulgor (°C)
Not applicable
Certificados de análise (COA)
Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Os clientes também visualizaram
Molecular ageing of alpha- and Beta-synucleins: protein damage and repair mechanisms
PLoS ONE, 8(4), e61442-e61442 (2013)
SAR228810: an antibody for protofibrillar amyloid ? peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA)
Alzheimer's Research & Therapy, 10(1), 117-117 (2018)
The many faces of ?-synuclein: from structure and toxicity to therapeutic target
Nature Reviews. Neuroscience, 14, 38-48 (2013)
Emerging Approaches to Investigate the Influence of Transition Metals in the Proteinopathies
Cells, 8(10), 1231-1231 (2019)
Alpha-synuclein structure and Parkinson?s disease ? lessons and emerging principles
Mol. Neurodegener., 14 (2019)
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica